e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interferon-gamma release assays for diagnosis of active pleural tuberculosis: a developing world perspective
Shah K., Udwadia Z.
Source:
Eur Respir J 2011; 38: 746
Journal Issue:
September
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Shah K., Udwadia Z.. Interferon-gamma release assays for diagnosis of active pleural tuberculosis: a developing world perspective. Eur Respir J 2011; 38: 746
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Role of interferon-gamma quantification for the diagnosis of pleural tuberculosis: a meta-analysis
Source: Eur Respir J 2001; 18: Suppl. 33, 499s
Year: 2001
Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting?
Source: Eur Respir J 2011; 38: 649-656
Year: 2011
Diagnosis of tuberculosis: principles and practice of using Interferon-gamma release assays (IGRAs)
Source: Breathe 2009; 5: 302-309
Year: 2009
Distinction tuberculosis from
Mycobacterium avium
complex disease using interferon-gamma release assay
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
T-cell interferon-γ release assay for the diagnosis of tuberculous pleuritis in routine clinical practice
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007
Utility of quantitative T-cell responses versus unstimulated interferon-gamma for the diagnosis of pleural tuberculosis
Source: Eur Respir J 2009; 34: 1118-1126
Year: 2009
Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1238-1239
Year: 2011
Interferon gamma assays in the diagnosis of TB pleuritis
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006
Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1237-1238
Year: 2011
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of
mycobacterium tuberculosis
infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
Clinical utility of the interferon-gamma for the diagnosis of active pulmonary tuberculosis
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014
Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007
Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept